The endothelin system in human saphenous vein graft disease (Q34443220)

2 August 2017

1 reference

title

The endothelin system in human saphenous vein graft disease (English)

1 reference

2 August 2017

J J Maguire

2

0 references

author name string

A P Davenport

series ordinal

1

1 reference

2 August 2017

publication date

1 April 2001

1 reference

Current Opinion in Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

176-182

1 reference

Pharmacology of coronary artery bypass grafts

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Aortocoronary bypass saphenous vein graft atherosclerosis. Anatomic study of 99 vein grafts from normal and hyperlipoproteinemic patients up to 75 months postoperatively

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Changes in grafts and coronary arteries after saphenous vein aortocoronary bypass surgery: results at repeat angiography

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Morphologic changes in long-term saphenous vein bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Intravascular ultrasound assessment of the presence of vascular remodeling in diseased human saphenous vein bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

ETA receptor‐mediated constrictor responses to endothelin peptides in human blood vessels in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Growth regulatory properties of endothelins

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Tissue concentrations of endothelins and functional effects of endothelin-receptor activation in human arteries and veins

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Endothelin-1 expression in vein graft stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Expression of endothelin-1 and constitutional nitric oxide synthase messenger RNA in saphenous vein endothelial cells exposed to arterial flow shear stress

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

In situ endothelin in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Secretory pathways in endothelin synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

1 reference

7 January 2021

Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for up-regulation of endothelin-converting enzyme activity in disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Endothelin-converting enzyme in the human vasculature: evidence for differential conversion of big endothelin-3 by endothelial and smooth-muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Tissue endothelin-converting enzyme activity correlates with cardiovascular risk factors in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Cellular Expression of Isoforms of Endothelin-Converting Enzyme-1 (ECE-1c, ECE-1b and ECE-1a) and Endothelin-Converting Enzyme-2

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Endothelin receptor expression and pharmacology in human saphenous vein graft

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Endothelin Peptide and Receptors in Human Atherosclerotic Coronary Artery and Aorta

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Detection of endothelin receptors in human coronary artery vascular smooth muscle cells but not endothelial cells by using electron microscope autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Importance of the phenotypic state of vascular smooth muscle cells on the binding and the mitogenic activity of endothelin

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Circulating immunoreactive endothelin in ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Plasma endothelin-1 levels in adult patients undergoing coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Effect of endothelin on normal and diseased human coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

PD156707: A Potent Antagonist of Endothelin-1 in Human Diseased Coronary Arteries and Vein Grafts

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Different proliferative properties of smooth muscle cells of human arterial and venous bypass vessels: role of PDGF receptors, mitogen-activated protein kinase, and cyclin-dependent kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Molecular mechanisms in intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Endothelin-1 is a mediator of intimal hyperplasia in organ culture of human saphenous vein

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Endothelin-1 stimulates proliferation of human coronary smooth muscle cells via the ET(A) receptor and is co-mitogenic with growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Endothelin-B receptors mediate intimal hyperplasia in an organ culture of human saphenous vein

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Endothelin-1 stimulates tyrosine phosphorylation and the activities of two mitogen-activated protein kinases in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

The seven-transmembrane-spanning receptors for endothelin and thrombin cause proliferation of airway smooth muscle cells and activation of the extracellular regulated kinase and c-Jun NH2-terminal kinase groups of mitogen-activated protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Evidence that angiotensin II, endothelins and nitric oxide regulate mitogen-activated protein kinase activity in rat aorta

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: reversal of endothelin-1 stimulatory effects

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

The effect of protein kinase C and its alpha subtype on human vascular smooth muscle cell proliferation, migration and fibronectin production

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Endothelin-1 causes a prolonged protein kinase C activation and acts as a co-mitogen in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Endothelin-1 stimulates DNA synthesis of vascular smooth-muscle cells through transactivation of epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Orally active endothelin receptor antagonist BMS-182874 suppresses neointimal development in balloon-injured rat carotid arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Selective antagonism of the ET(A) receptor reduces neointimal hyperplasia after balloon-induced vascular injury in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

Altered endothelin-1 binding following balloon angioplasty of pig coronary arteries: effect of the ETA receptor antagonist, LU 135252

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900026-1

7 January 2021

10.1016/S1471-4892(01)00026-1

Identifiers

DOI

1 reference

2 August 2017

1 reference